William B. Stilley Iii Adial Pharmaceuticals, Inc. (ADIL) insider trading activity

William B. Stilley Iii is Director of ADIAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.26 Million shares of ADIL, which is worth approximately $1.3 Million. The most recent transaction as insider was on May 23, 2023, when has been sold 240,800 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.26M

0% 3M change

0% 12M change

Total Value Held $1.3 Million

William B. Stilley III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2023	BUY Grant, award, or other acquisition	-	240,800 Added 16.03%	1,261,779 Common Stock
Dec 30 2022	SELL Sale (or disposition) back to the issuer	-	166,667 Reduced 14.03%	1,020,979 Common Stock
Feb 23 2022	BUY Grant, award, or other acquisition	-	250,000 Added 17.39%	1,187,646 Common Stock
Nov 30 2021	BUY Open market or private purchase	$29,150 $2.75 p/Share	10,600 Added 1.12%	937,646 Common Stock
Nov 29 2021	BUY Open market or private purchase	$25,900 $2.59 p/Share	10,000 Added 1.07%	927,046 Common Stock
Jan 26 2021	BUY Grant, award, or other acquisition	-	201,109 Added 17.99%	917,046 Common Stock

Also insider at

SYSX

Sysorex, Inc. Financial Services

Director

AVCO

Avalon GloboCare Corp. Real Estate

Director

WBS